Invention Grant
- Patent Title: HIV-1 south african subtype C env proteins
-
Application No.: US14141396Application Date: 2013-12-26
-
Publication No.: US09598469B2Publication Date: 2017-03-21
- Inventor: Jan Zur Megede , Susan Barnett , Ying Lian , Susan Engelbrecht , Estrelita Janse Van Rensberg , Thomas J. Scriba
- Applicant: Novartis Vaccines and Diagnostics, Inc. , University of Stellenbosch
- Applicant Address: US NJ East Hanover ZA Tygerberg
- Assignee: Novartis Vaccines and Diagnostics, Inc.,University of Stellenbosch
- Current Assignee: Novartis Vaccines and Diagnostics, Inc.,University of Stellenbosch
- Current Assignee Address: US NJ East Hanover ZA Tygerberg
- Agency: Morrison & Foester LLP
- Main IPC: A61K39/21
- IPC: A61K39/21 ; C07K14/005 ; C12N15/86 ; A61K39/12 ; A61K39/00
Abstract:
The present invention relates to polynucleotides encoding immunogenic HIV polypeptides. Uses of the polypeptides in applications including immunization, generation of packaging cell lines, and production of HIV polypeptides are also described. Polynucleotides encoding antigenic HIV polypeptides are described, as are uses of these polynucleotides and polypeptide products therefrom, including formulations of immunogenic compositions and uses thereof.
Public/Granted literature
- US20140220060A1 HIV-1 SOUTH AFRICAN SUBTYPE C ENV PROTEINS Public/Granted day:2014-08-07
Information query
